XML 76 R13.htm IDEA: XBRL DOCUMENT v3.20.1
Note 7 - Notes Payable
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Debt Disclosure [Text Block]
7.
Notes Payable
 
Notes payable consists of the following (in thousands, except percentages) as of:
 
   
 
 
 
 
 
 
 
 
December 31,
   
December 31,
 
   
Current
   
Long-term
   
201
9
   
201
8
 
New Credit Facility with CoBank, ACB; variable interest rate of 5.95% and 6.77% at December 31, 2019 and 2018, respectively. Interest is quarterly and paid in arrears on the last business day of each quarter. The New Credit Facility is secured by the total assets of the subsidiary guarantors. The unpaid balance is due November 3, 2022.
  $
4,350
    $
65,862
    $
70,212
    $
74,562
 
                                 
Debt issuance cost
   
(421
)    
(690
)    
(1,111
)    
(1,551
)
                                 
Notes payable, net of debt issuance cost
  $
3,929
    $
65,172
    $
69,101
    $
73,011
 
 
 
The Senior Loan Agreement was fully repaid on
November 2, 2017.
Associated with the Senior Loan Agreement, the Company had
$4.9
million in deferred financing cost. Amortization expense for the deferred financing cost associated with the Senior Loan Agreement was
$896
thousand for the year ended
December 31, 2017,
which is included in interest expense. The Company wrote off
$3,070
thousand of prior deferred financing cost and incurred
$14
thousand in external legal fees during the year ended
December 31, 2017,
as a result of the extinguishment of the Senior Loan Agreement, which is included in interest expense.
 
The Subordinated Loan Agreement was fully repaid on
November 2, 2017.
Associated with the Subordinated Loan Agreement, the Company had
$892
thousand in deferred financing cost. Amortization expense for the deferred financing cost associated with the Subordinated Loan Agreement was
$133
thousand for the year ended
December 31, 2017,
which is included in interest expense. The Company wrote off
$621
thousand of prior deferred financing cost and incurred
$14
thousand in external legal fees during the year ended
December 31, 2017,
as a result of the extinguishment of the Subordinated Loan Agreement, which is included in interest expense.
 
Associated with the New Credit Facility, the Company has
$2.1
million in deferred financing cost. Amortization expense for the deferred financing cost associated with the New Credit Facility was
$452
thousand,
$476
thousand and
$75
thousand for the years ended
December 31, 2019,
2018
and
2017,
respectively, which is included in interest expense.
 
The Company had a revolving credit facility of
$5.0
million associated with the Senior Loan Agreement. There was
no
balance outstanding during
2017.
The Senior Loan Agreement was terminated on
November 2, 2017.
The Company paid a monthly fee of
0.75%
per annum on the unused portion of the revolver loan under the Senior Loan Agreement, payable in arrears. The fee expense was
$32
thousand for the year ended
December 31, 2017.
 
The revolving credit facility associated with the Company’s New Credit Facility has a maximum borrowing capacity of
$5.0
million. The revolving credit facility is available until
November 3, 2022.
There was
no
balance outstanding as of
December 31, 2019
or
2018.
The Company pays a commitment fee, payable quarterly in arrears, on the unused portion of the revolver loan under the New Credit Facility. The rate declined from
0.50%
per annum to
0.38%
per annum on
October 22, 2018.
The commitment fee expense was
$19
thousand,
$24
thousand and
$4
thousand for the years ended
December 31, 2019,
2018
and
2017,
respectively.
 
Maturities of notes payable for the next
four
years, assuming
no
annual excess cash flow payments, are as follows (in thousands):
 
2020
  $
4,350
 
2021
   
4,350
 
2022
   
61,512
 
2023
   
 
Total
  $
70,212
 
 
The Company’s notes payable agreements are subject to certain financial covenants and restrictions on indebtedness, financial guarantees, business combinations and other related items. As of
December 31, 2019,
the Company was in compliance with all such covenants and restrictions.